-
RETRACTION: Novel C‐Terminal Heat Shock Protein 90 Inhibitors Target Breast Cancer Stem Cells and Block Migration, Self‐Renewal, and Epithelial–Mesenchymal Transition
-
LOXL 2 Promotes the Epithelial–Mesenchymal Transition and Malignant Progression of Cervical Cancer [Retraction]
-
COMP–PMEPA1 axis promotes epithelial‐to‐mesenchymal transition in breast cancer cells
-
Suppressing M2 Macrophage Polarization by Glycine Combined with β-Elemene via the IL-6/JAK2/STAT3 Signaling Pathway to Inhibit Triple-Negative Breast Cancer Progression
-
The Role of Enterococcus faecium in the Synergistic Clearance of High‐Risk HPV: A Clinical Study on Cervicovaginal Microbiota Regulation
-
The Influence of Social Media Messaging on Human Papillomavirus Vaccine Attitudes and Confidence Among Adolescent Males: Group Discussion Study
-
Cholesterol‐Lowering Treatment Blocks Epithelial‐Mesenchymal Transition (EMT) Associated Invasiveness and Drug Resistance in Breast and Colorectal Adenocarcinoma Models
-
miR-214-3p Inhibits Epithelial-to-Mesenchymal Transition and Metastasis of Endometrial Cancer Cells by Targeting TWIST1 [Retraction]
-
MFAP2 Promotes Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Activating TGF-β/SMAD2/3 Signaling Pathway [Retraction]
-
RETRACTION: FLOT1 promotes tumor development, induces epithelial–mesenchymal transition, and modulates the cell cycle by regulating the Erk/Akt signaling pathway in lung adenocarcinoma
-
Correction to “Mifepristone increases mRNA translation rate, triggers the unfolded protein response, increases autophagic flux, and kills ovarian cancer cells in combination with proteasome or lysosome inhibitors”
-
Kikuchi-Fujimoto disease mimicking tuberculous lymphadenitis or lymphoma on fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography
-
CLDN18.2-Directed Therapeutics in Gastric and Gastroesophageal Junction Adenocarcinoma: Biomarker Assessment, Expression Dynamics, and Treatment Sequencing
-
MRI and 18F-fluorothymidine PET-MR for the early evaluation of renal and bone marrow effects in 177Lu-DOTATATE therapy
-
The role of human papillomavirus (HPV) E6 proteins as a risk factor for oesophageal cancer
-
AC067930.4/miR-375 Axis Regulates the Malignant Progression of Colon Adenocarcinoma Through the Cuproptosis-Related Gene SLC6A6
-
Oophorectomy‐Corrected Ovarian Cancer Incidence, Survival, and Mortality by Subtype, Race, Ethnicity
-
Correction to “Differential activity of MEK and ERK inhibitors in BRAF inhibitor resistant melanoma”
-
Novel Insights into the Oncogenic Role and Clinical Significance of ORC6L in Breast Cancer
-
Clinical Application of the Right Liver Hanging Maneuver for Laparoscopic Resection of Segment 6 Hepatocellular Carcinoma
-
Correction to: Survivorship in advanced ovarian cancer: a prognostic model for overall survival and risk of recurrence
-
RNA‐binding protein RBMS1: A new target for cancer diagnosis and treatment
-
Identification of serum protein biomarkers for pre‐cancerous lesions associated with pancreatic ductal adenocarcinoma
-
Multi‐Omics Analysis Reveals Differentially Expressed Proteins and Metabolites in Malignant Pleural Effusion